secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cibus, Inc. (CBUS)
CIK:        0001705843
Form:       8-K
Filed at:   2026-05-14T20:11:14+00:00
Accession:  0001628280-26-035105
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cibus Q1 net loss narrows to $21.2M; Rice HT U.S. launch pushed to 2029
-----------------------------------------------------------------------

- Net loss of $21.2M ($0.33/share) vs $49.4M ($1.34) in Q1 2025; no goodwill impairment this quarter.
- Cash at $30.3M; net cash usage guidance of ~$30M or less in 2026.
- Rice HT program: U.S. launch rescheduled to 2029 due to herbicide registration delay; LATAM launch still targeted for 2027.
- Q1 revenue increased YoY; R&D down 26% to $8.7M, SG&A down 48% to $5.1M on cost cuts.
- Raised ~$37.3M in two equity offerings YTD 2026; Thomas Urban appointed to Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1705843/000162828026035105/0001628280-26-035105-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1705843/000162828026035105/cbus-20260514.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-035105

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer